A 3D microtumour system that faithfully represents ovarian cancer minimal residual disease
<p><strong>Background</strong> Bulk cancer and minimal residual disease (MRD) are characterised by different molecular drivers and therefore necessitate different therapeutic strategies. However, there are currently no 3D models that can faithfully recapitulate MRD ex vivo for ther...
Principais autores: | Yang, X, Artibani, M, Jin, Y, Aggarwal, A, Zhang, Y, Munoz-Galvan, S, Mikhailova, E, Rai, L, Mukherjee, N, Krishna Kumar, R, Albukhari, A, Zhou, L, Ahmed, AA, Bayley, H |
---|---|
Formato: | Internet publication |
Idioma: | English |
Publicado em: |
2023
|
Registros relacionados
-
3D Microtumours fabricated by microfluidics: applications in ovarian cancer
por: Yang, X
Publicado em: (2023) -
Role of immunotherapy in ovarian cancer: a narrative review
por: Romanchik, D, et al.
Publicado em: (2022) -
Retraction Note: Visualising the dynamics of live pancreatic microtumours self-organised through cell-in-cell invasion
por: Yukiko Miyatake, et al.
Publicado em: (2024-10-01) -
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
por: Artibani, M, et al.
Publicado em: (2021) -
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
por: Mara Artibani, et al.
Publicado em: (2021-06-01)